13/12/2021
EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
25/05/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
29/04/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
31/03/2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
24/09/2020
Genome editing is an advance in biological tools with the potential for a wide range of applications.
24/08/2020
This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
30/06/2020
EuropaBio welcomes the European Commission’s commitment to develop a European plan to fight cancer and is supportive of its overarching approach in tackling all key stages of the disease: prevention, early diagnosis, treatment, and quality of life. Above all, we strongly advocate the employment of supportive measures for health innovation to ensure that novel cancer treatments move from the laboratory to the hospital bedside as swiftly as possible.
20/05/2020
Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe.
20/05/2020
EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. In medicine, genome editing offers the prospect of saving lives and tackling some of the most devastating genetic diseases.
30/04/2020
The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner?
30/04/2020
A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
30/03/2020
Learn how biotechnology can contribute towards fighting COVID-19 in our latest blog post.
29/02/2020
Read our newest blog on the occasion of Rare Disease Day on the 29th of February.
26/01/2020
A combination of antiviral therapy and genome editing has succeeded in removing the HIV virus from infected mice.
25/01/2020
Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer.
15/01/2020
Treatment for certain cancers has taken a huge leap forward thanks to new “living drugs”, created through biotechnology.